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and RTC death, both apoptosis and necrosis, induced by cis-Direct involvement of the receptor-mediated apoptotic path-
platin were more severe in B6 mice in vivo.ways in cisplatin-induced renal tubular cell death.
Conclusion. Based on these data, we conclude that the Fas-Background. Tumor necrosis factor (TNF) receptor family
and TNFR1-mediated apoptotic pathways are directly involvedmembers, such as Fas and TNF receptor 1 (TNFR1), are thought
in the pathogenesis of cisplatin-induced RTC death process.to induce apoptosis in a variety of cells and organs. Although
a number of potential scenarios have been postulated for the
involvement of these receptors in the pathogenesis of acute
renal failure (ARF), direct evidence for their involvement in Experimental models of acute renal failure (ARF) in-
death of renal tubular cells (RTCs) and renal dysfunction is duced by ischemia-reperfusion or nephrotoxic drugs ex-preliminary.
hibit morphological damage involving a variable degreeMethods. This study examined the roles of these receptors
of necrosis, especially of the S3 segment of the proximalin RTC death in two systems: (1) in vivo murine and rat models
of cisplatin-induced ARF, and (2) murine proximal tubular tubules [1]. This tubular damage results in severe and acute
cells (PTCs), which were isolated from C57BL/6 (B6) mice, Fas- reduction of the glomerular filtration rate, accompanied
mutant B6-lpr/lpr mice and TNFR1-deficient mice, and normal by increased serum concentrations of blood urea nitro-
rat kidney (NRK52E) cells in vitro.
gen (BUN) and creatinine. On the other hand, apoptosisResults. Reverse transcription-polymerase chain reaction in-
has emerged as an important general mechanism bydicated cisplatin-induced up-regulation of Fas, Fas ligand and
which renal tubular cells (RTCs) are injured, when sub-TNF- mRNAs in the kidney in vivo and in RTCs in vitro,
both in mice and rats. In contrast, the level of TNFR1 mRNA jected to a variety of stimuli, including ischemia [2–4],
was substantial but did not change in response to cisplatin. nephrotoxins [5], obstruction [6], polycystic disease [7],
TNF- production in cell culture medium determined by enzyme- and transplant rejection [8], at an intensity below the
linked immunosorbent assay (ELISA) and Fas expression de-
threshold for necrotic cell death [9]. Although activationtermined by fluorescence-activated cell sorter (FACS) analysis
of endonucleases [10] has been implicated in the finalincreased following incubation with cisplatin in B6 PTCs. In
order to examine whether Fas and TNFR1 are directly involved postmortem phase [11], the proximal pathways involved
in RTC death and renal dysfunction, we compared cell resis- in the stimulus recognition, signal transduction, and ef-
tance to cisplatin using a cell viability assay and FACS analysis fector phases of RTC apoptosis are largely unknown.
with fluorescein isothiocyanate-conjugated annexin V and pro- A number of protein systems regulate the apoptoticpidium iodide staining. The ratios of cell viability loss and cell
events. One of these systems operates through the tumordeath, both from apoptosis and necrosis, were higher in B6 PTCs
necrosis factor (TNF) receptor family, including Fas anti-than in other cells, while the ratios were comparable between
Fas-mutant PTCs and TNFR1-deficient PTCs. Caspase-8 activ- gen (Fas, CD95, APO-1) and TNF receptor 1 (TNFR1).
ity was increased in B6 PTCs, but not in Fas-mutant PTCs and Both Fas and TNFR1 contain conserved death domains
TNFR1-deficient PTCs. Furthermore, the renal dysfunction in their cytoplasmic tails, which mediate defined protein-
protein interactions [12, 13], allowing recruitment of other
death domain-containing proteins such as Fas-associatedKey words: acute renal failure, Fas, TNF receptor, proximal tubule
death domain protein (FADD). The association of FADDcells, kidney dysfunction, necrosis, cytoprotection, death receptor-
mediated pathways. with Fas or TNFR1 results in recruitment of caspase-8,
activation of which consequently leads to cell death [14, 15].Received for publication November 27, 2001
Although a number of reports have documented Fas ex-and in revised form July 3, 2002
Accepted for publication August 14, 2002 pression on RTCs and up-regulation of Fas expression
during acute and chronic renal failure [4, 16–21], whether 2003 by the International Society of Nephrology
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Table 1. Sequences of upstream and downstream primers of rat and mice for RT-PCR analysis
Primer Anneal
temp Base
Species Gene 5 3 C Cycle pair
Rat Fas CTT TGA GGG TTT GGA GTT GA ATT TGG TGT TGC TGG TTC GT 54 30 404
FasL GCA ACA GCC AGC CCC TAA GC CCA CAC AGC AGC CCA AAA CT 55 30 472
TNF- TAC TGA ACT TCG GGG TGA TTG GTC C CAG CCT TGT CCC TTG AAG AGA ACC 59 32 295
TNFR1 GAC TGG TTC CTT CTC TTG GT GGT GTT CTG TTT CTC CTT AC 55 28 407
GAPDH TCC CTC AAG ATT GTC AGC AA AGA TCC ACA ACG GAT ACA TT 55 23 308
Mouse Fas TCC TGC CTC TGG TGC TTG CT TGT ATT GCT GGT TGC TGT GC 55 30 458
FasL GAG CAG TCA GCG TCA GAG TT GAT TTG TGT TGT GGT CCT TC 55 30 323
TNF- CCT CCC TCT CAT CAG TTC TA AGC CAT AAT CCC CTT TCT AA 55 32 634
TNFR1 TAC ATC CAT CAG GGG TCA CT AGG CAC AAC TTC ATA CAC TC 55 28 525
GAPDH GCA GTG GCA AAG TGG AGA TT GCA GAA GGG GCG GAG ATG AT 55 23 307
Abbreviations are: TNF-, tumor necrosis factor-alpha; TNFR1, TNF receptor 1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; anneal temp, annealing
temperature.
RTC apoptosis under those conditions depends on the weight (BW)] and to the mice by intraperitoneal injec-
tion (20 mg/kg BW). Rats and mice were sacrificed threeFas-Fas ligand (FasL) pathway remains controversial.
Information regarding the involvement of TNFR1 in or five days after injection. The kidneys were perfused
in situ via the aorta or the heart with phosphate-bufferedRTC apoptosis is limited and still preliminary [22–24].
Mice, in which TNFR1 expression was abolished, were saline (PBS), pH 7.4, and then excised for further analy-
ses. Control rats had saline injected instead of cisplatin.reported to be more sensitive to certain types of infection
and, in contrast, to exhibit increased resistance to endo- Reverse transcription (RT)-PCR. Total RNA was ex-
tracted from the rat kidneys using the TRIzol methodtoxin-induced lethality [25, 26]. However, to date there
has been no report investigating the inhibitory effect of according to the protocol recommended by the manu-
facturer (Gibco BRL, Grand Island, NY, USA). Equalthis receptor on RTC death.
In the present study, we examined the involvement of amounts (2.0 g) of DNA-free total RNA from each
sample were converted to cDNA using 200 U of Super-Fas and TNFR1 in RTC death using a cisplatin model
of ARF in vivo, and cultured RTCs in vitro. Our results Script II reverse transcriptase (Gibco) with 500 ng of
Oligo(dT)12-18 primer (Gibco), 0.5 mmol/L of each dNTPsuggest that both Fas- and TNFR1-mediated apoptotic
pathways contribute to RTC death in cisplatin-induced (Promega, Madison, WI, USA), and 40 U of RNasin
(Promega), in a 40-L reaction volume. Reverse tran-ARF, and lend support to the notion that inhibition of
death receptor-mediated pathways may offer a novel scription was performed at 22C for 10 minutes, at 42C
for 45 minutes, and at 95C for 5 minutes. The reactionapproach to the cytoprotection of RTCs from a variety
of stimuli. products (2.0 L) were subjected to PCR amplification
using 1.25 U of Taq DNA polymerase (Promega) in a
50-L reaction volume with 0.4 mol/L of each dNTP,
METHODS
0.4 mol/L of each specific primer, and 2 mmol/L MgCl2.
In vivo studies PCR was performed using the Perkin-Elmer (Foster
City, CA, USA) thermal cycler according to the instruc-Cisplatin-induced ARF in rats and mice. Male Sprague-
Dawley rats weighing 200 to 250 g were obtained from tions provided by the manufacturer. The published se-
quences of rat and mouse Fas, FasL, TNF-, TNFR1, andKyudo (Kumamoto, Japan). C57BL/6 (B6, wild-type) mice
and C57BL/6-lpr/lpr (Fas-mutant) mice were obtained glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
mRNA were retrieved from the Genbank database, andfrom Japan SLC (Hamamatsu, Japan). TNFR1-deficient
(TNFR1/) mice with a C57BL/6 background were a primer pairs for each were designed with oligonucleotide
software (Oligo Primer Analysis Software, version 5.0;kind gift from Dr. Tak Wah Mak, Amgen Institute, Uni-
versity of Toronto. The animals were housed individually National Biosciences, Plymouth, MN, USA). Primer se-
quences and PCR conditions are shown in Table 1. Wein standard laboratory cages and treated according to
the principles outlined in the Guide for the Care and determined the number of cycles for PCR of each gene
by checking whether the amount of PCR product in-Use of Laboratory Animals of the National Institutes of
Health (Bethesda, MD, USA). Approval for the animal creased linearly in proportion to the increase in number
of cycles and was directly proportional to the numberexperiments was obtained in advance from the Animal
Ethics Experimentation Committee of our institution. Cis- of cycles in the exponential range of amplification. The
resulting amplification products were sequenced and wereplatin (Sigma, St. Louis, MO, USA) was administered to
the rats by a single intravenous injection [8 mg/kg body confirmed the identities of the fragments.
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Equal volumes of the amplification products were ana- bated with 0.5 mg/mL collagenase (Sigma) in Hanks’ solu-
tion (Gibco) for one hour and the cell suspension waslyzed by agarose gel (1.5%) electrophoresis with ethid-
ium bromide (0.5 mg/mL) staining. Gels were photo- sieved through steel meshes (250 m, 150 m, 75 m, and
38 m). After centrifugation at 200  g for five minutes,graphed and analyzed using the public domain National
Institutes of Health (NIH) Image program (http://rsb. cells were washed twice with PBS, and cultured in the
growth medium.info.nih.gov/nih-image/). The results were normalized to
the intensity of GAPDH bands. Cell culture and cisplatin stimulation. Murine PTCs were
cultured in 1:1 mixture of Dulbecco’s modified Eagle’sMeasurement of plasma BUN. Plasma BUN levels were
measured using the urease-UV method by SRL Labora- medium and Ham’s F-12 (DMEM/F-12; Gibco) contain-
ing the following additives; 25 mmol/L HEPES (Gibco),tories (Tokyo, Japan).
Morphological assessment. Three days after cisplatin 100 U/mL penicillin (Gibco), and 100 g/mL streptomy-
cin (Gibco), 10% fetal calf serum (FCS; Gibco), 5 g/mLinjection, kidneys were excised from mice, immersed in
Bouin’s solution and fixed for 12 to 24 hours, and then insulin (Sigma), 5 g/mL transferrin (Sigma), 1 ng/mL
prostaglandin E1 (PGE1; Sigma), 5 1011 mol/L triiodo-embedded in paraffin and 3-m sections were mounted
on silane-coated glass slides. After deparaffinization and thyronine (Sigma), 108 mol/L sodium selenite (Sigma),
5  108 mol/L hydrocortisone (Sigma), and 25 ng/mLrehydration, the tissues were stained with periodic acid-
Schiff (PAS), and the degree of morphological evidence epidermal growth factor (Sigma). Normal rat kidney
(NRK52E) cells were obtained from the American Typeof renal failure was determined using light microscopy,
as described by Megyesi et al with some modifications Culture Collection (ATCC, Manassas, VA, USA) and
cultured in RPMI 1640 medium (Gibco) containing 10%[27], by an investigator blinded to the treatment protocol.
Briefly, the following morphological parameters were FCS. The cultured cells were incubated with various
concentrations of cisplatin or vehicle (PBS) for 24, 48,selected to assess the severity of cisplatin-induced dam-
age of the kidney: loss of proximal tubule brush border, or 72 hours for the following analyses.
RT-PCR. Total RNA was extracted by the TRIzoltubule degeneration, tubule necrosis, and tubular cast
formation. These parameters were evaluated on a scale method from NRK52E cells according to the protocol
provided by the manufacturer, following the manipula-of 0 to 4, which ranged from not present (0), mild (1),
moderate (2), severe (3), to very severe (4). Each param- tions described earlier in the in vivo study.
Fas expression on the surface of PTCs. Cell surfaceeter was determined in at least five different animals.
Apoptosis assay. Histological aspects of apoptosis were Fas expression on murine PTCs was examined by fluo-
rescence-activated cell sorter (FACS) analysis using astudied by a standard terminal deoxynucleotidyl trans-
ferase (TdT)-mediated dUTP nick end-labeling (TUNEL) fluorescein isothiocyanate (FITC)-conjugated monoclonal
hamster antibody to murine Fas (PharMingen, San Diego,assay using ApopTag Plus Kit (Intergen, Inc., Gaithers-
burg, MD, USA) according to the instructions provided CA, USA). After incubation with either 8 mol/L cis-
platin or vehicle for 72 hours, the murine PTCs wereby the manufacturer. Briefly, 3-m sections fixed in 10%
formalin were pretreated for 30 minutes with PBS con- trypsinized and washed, and then incubated in the dark
with 10 L of either an anti-Fas antibody or a controltaining 3% H2O2, and then washed and incubated with
proteinase K (20 g/mL; Roche, Mannheim, Germany) antibody (FITC-conjugated hamster IgG; PharMingen)
in Hanks’ solution with 10% FCS for 30 minutes at 4C.at room temperature for 15 minutes. The sections were
incubated with TdT and a mixture of digoxygenin-labeled After incubation, the cells were washed twice, resus-
pended in 200 L of PBS, and then analyzed on a FACS-nucleotides for 60 minutes. This was followed by incuba-
tion with anti-digoxygenin-peroxidase for 30 minutes and Calibur flow cytometer (Becton Dickinson, San Jose,
CA, USA) and the data were analyzed using CELL-color development with H2O2-diaminobenzidine for three
to six minutes. Then, the slides were counterstained with QUEST software (Becton Dickinson).
TNF- protein excretion in cell culture medium. TNF-hematoxylin. For positive controls, specimens of thyroid
tissue were provided by Intergen. Negative controls were protein excretion in cell culture medium of PTCs after
incubation with cisplatin or vehicle for 24, 48, or 72 hoursperformed by omission of TdT enzyme from the incuba-
tion buffers. was measured using an enzyme-linked immunosorbent
assay (ELISA) kit according to the protocol recommended
In vitro studies by the manufacturer (BioSource International, Cama-
rillo, CA, USA).Isolation of murine proximal tubular cells (PTCs). Mu-
rine PTCs were cultured from collagenase-digested frag- Activity of caspase-8. Activity of caspase-8 in RTCs af-
ter incubation with cisplatin or vehicle for 72 hours wasments of the proximal tubules obtained from the cortices
of C57BL/6 mice, C57BL/6-lpr/lpr mice and TNFR1/ measured using ApoAlert Caspase-8 Colorimetric Assay
Kit according to the protocol recommended by the man-mice with a modification of methods described by Wuth-
rich et al [28]. Briefly, cortices were minced and incu- ufacturer (Clontech, La Jolla, CA, USA).
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Fig. 2. mRNA expression of death receptors and their ligands in cul-
tured renal tubular cells determined by RT-PCR. Representative ex-
pression of FasL, Fas, TNF- and TNFR1 mRNAs in NRK52E cells
(A) and in cultured PTCs of C57BL/6 mice (B) are shown after incuba-
tion with vehicle (Control) or cisplatin for the indicated times.
Fig. 1. mRNA expression of death receptors and their ligands in rat
and murine kidneys determined by RT-PCR. (A) Representative ex- Cell death assay. Cell death was assayed by FACS
pression of FasL, Fas, tumor necrosis factor- (TNF-), and TNF recep-
analysis with FITC-conjugated annexin V (PharMingen)tor 1 (TNFR1) mRNAs in control kidneys or in kidneys 3 days (Day 3)
and 5 days (Day 5) after cisplatin injection. (B) Mean mRNA levels and propidium iodide (PI; PharMingen). Murine PTCs
of these genes, quantified using NIH image software and normalized were incubated with either 8 mol/L cisplatin or vehicle
to the intensity of GAPDH bands, in control kidneys () and in kidneys
for 72 hours. The cells were trypsinized, washed, and in-3 days ( ) and 5 days () after cisplatin injection are shown as a ratio
of mean mRNA levels in control kidneys. The ratios represent means cubated with FITC-conjugated annexin V and PI in bind-
( SEM). *P  0.05, **P  0.01 compared to control kidneys. ing buffer at concentrations suggested by the manufac-
turer on ice in the dark for 15 minutes. Stained cells
were analyzed on a FACSCalibur flow cytometer. Data
were analyzed using CELL-QUEST software.Cell viability assay. Cell viability was determined by
the WST-1 assay, as described by Kawahara et al [29].
Statistical analysisIn brief, the murine PTCs (5  104 cells in 100 L) were
Data are expressed as mean SEM. One-way analysistreated with various concentrations of cisplatin. WST-1
of variance (ANOVA) with the Bonferroni modifiedreagents, 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disul-
t test was used for comparison with control values infophenyl)-2H-tetrazolium monosodium salt (Dojin Labo-
the RT-PCR assay and with wild-type (C57BL/6) mice.ratories, Kumamoto, Japan) and 1-methoxy-5-methyl-
Mann-Whitney’s U-test (non-parametric analysis) wasphenazinium methylsulfate (Dojin Laboratories), were
used for comparison with control values in ELISA ofadded to the cells at final concentrations of 5.0 and 0.2
TNF- and caspase-8 assay. Survival data were analyzedmmol/L, respectively, and incubated for one hour at
by Kaplan-Meier using log rank analysis to compare37C. Using an ELISA autoreader, cell viability was de-
survival curves. Statistical significance was accepted attermined by measuring the difference between the ab-
sorbance at 450 and 620 nm. P  0.05.
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RESULTS
Cisplatin-induced up-regulation of Fas, FasL and
TNF- mRNA expression in the kidneys of rats
and B6 mice in vivo, and NRK52E cells and
B6 PTCs in vitro
In the in vivo study, low expression levels of FasL,
Fas and TNF- mRNAs were observed in the kidneys
of control rats and B6 mice. The mRNA levels of these
genes were up-regulated after cisplatin injection. In con-
trast, the level of TNFR1 mRNA was substantial in con-
trol kidneys, but was not altered by cisplatin injection
in rats and was slightly increased in mice (Fig. 1A). The
signal densities were quantified using the NIH image
program and results were normalized to the intensity of
GAPDH bands. Mean mRNA levels of these genes in
control kidneys and in insulted kidneys three and five
days after cisplatin injection are shown as a ratio to mean
mRNA levels in control kidneys in Figure 1B.
In the in vitro study, low expression levels of FasL,
Fas and TNF- mRNAs were observed also in NRK52E
cells and in B6 PTCs in the absence of cisplatin stimula-
tion. The mRNA levels of these genes were increased
by incubation with 8 mol/L cisplatin for over 24 hours.
Similar to the findings in the in vivo study, TNFR1
mRNA levels were substantial and constant, irrespective
of stimulation by cisplatin (Fig. 2).
Up-regulation of Fas expression on the surface of
murine PTCs by cisplatin stimulation
FACS analysis revealed Fas expression on the surface
of PTCs of C57BL/6 and TNFR1/ mice and the expres-
sion levels were increased by incubation with 8 mol/L
cisplatin for 72 hours. However, no positive staining was
observed on the surface of PTCs of C57BL/6-lpr/lpr
mice, irrespective of stimulation by cisplatin (Fig. 3).
Increased production of TNF- protein in the medium
of murine PTCs by cisplatin stimulation
ELISA analysis for TNF- in the medium of B6 PTCs
revealed that TNF- production by PTCs increased fol-
lowing incubation with 8 mol/L cisplatin and remained
elevated over a period of more than 24 hours (Fig. 4).
Activation of caspase-8 in NRK52E cells and B6
PTCs by cisplatin stimulation
Caspase-8 activity assay revealed that the levels of cas-
pase-8 activity in NRK52E cells and B6 PTCs incubated
Fig. 3. Effects of cisplatin on Fas protein expression on the cell surface
of murine proximal tubular cells (PTCs). Representative Fas protein C57BL/6 (A) and TNFR1/ mice (C), whereas in C57BL/6-lpr/lpr mice,
expression on the surface of murine PTCs isolated from C57BL/6 mice the levels are low and comparable between stimulated and unstimulated
(A), C57BL/6-lpr/lpr mice (B), and TNFR1/ mice (C ) was identified cells. The data represent three independent experiments. The upper
by FACS analysis using a monoclonal hamster antibody to murine Fas. values (fine lines) indicate percentages of positive staining for anti-Fas
The levels of fluorescence on the cisplatin-stimulated PTCs (bold lines) antibody in PTCs stimulated with vehicle and the lower values (bold
are higher than those on the vehicle-stimulated PTCs (fine lines) in mice lines) indicate those stimulated with cisplatin.
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Fig. 4. Effects of cisplatin on TNF- protein production by cultured
renal tubular cells. The PTCs of C57BL/6 mice were incubated with 8
mol/L cisplatin () or vehicle () for the indicated time. TNF-
concentrations in cell culture medium determined by enzyme-linked
immunosorbent assay are shown. *P  0.05 compared to Control.
Fig. 6. Renal function of cisplatin-injected mice. Plasma levels of BUN
3 days (Day 3) and 5 days (Day 5) after cisplatin injection are shown
in C57BL/6 mice (), C57BL/6-lpr/lpr mice ( ), and TNFR1/ mice
(). Values, in milligrams per deciliter, represent means ( SEM) of
at least five mice. *P  0.05 compared to C57BL/6 mice.
C57BL/6-lpr/lpr mice and TNFR1/mice than of C57BL/6
mice (Fig. 7 B, C). These histological parameters are
quantified in Figure 7D. The numbers of TUNEL-posi-
tive apoptotic cells observed in outer medulla three days
after cisplatin injection were significantly smaller in kid-
neys of C57BL/6-lpr/lpr mice and TNFR1/ mice than
of C57BL/6 mice (Fig. 8).
The cell viability assay revealed a significant dose-
dependent loss of cell viability by incubation with variousFig. 5. Effects of cisplatin on caspase-8 activity in cultured renal tubular
cells. NRK52E cells and PTCs of C57BL/6 mice, C57BL/6-lpr/lpr mice, concentrations (2, 4, or 8 mol/L) of cisplatin for 72 hours
and TNFR1/ mice were incubated with 8 mol/L cisplatin () or in all kinds of PTCs. However, PTCs of C57BL/6-lpr/lpr
vehicle (Control; ) for 72 hours. Activities of caspase-8 are shown as
mice and TNFR1/ mice were significantly more resistantpercent change from Control. *P  0.05 compared to Control. #P 
0.05 compared to C57BL/6 mice. to cisplatin stimulation than those of C57BL/6 mice (Fig. 9).
FACS analysis demonstrated increased ratios of an-
nexin V-positive (apoptotic) cells and PI-positive (necrotic)
cells, in PTCs of C57BL/6 mice, following incubation with
with 8 mol/L cisplatin for 72 hours were significantly 8 mol/L cisplatin for 72 hours (Fig. 10A). However, no
higher than in those cells incubated with vehicle. How- increases were seen in these ratios in PTCs of C57BL/6-
ever, only slight increases were observed in the PTCs of lpr/lpr mice and TNFR1/ mice (Fig. 10 B, C).
C57BL/6-lpr/lpr mice and TNFR1/ mice after stimula-
tion by cisplatin (Fig. 5). Effects of Fas or TNFR1 gene ablation on decrease
of mortality after cisplatin administration
Effects of Fas or TNFR1 gene ablation on amelioration
All genotypes of mice had a high mortality after theof RTC death and renal dysfunction induced by cisplatin
20 mg/kg cisplatin injection in this study. We compared
Serum levels of BUN three days and five days after the survival rate after cisplatin injection among all three
cisplatin injection were significantly lower in C57BL/6- genotypes of mice. As a result, the survival rate was sig-
lpr/lpr mice and TNFR1/ mice than in C57BL/6 mice nificantly higher in C57BL/6-lpr/lpr mice and TNFR1/
(Fig. 6). Histological examination of kidneys excised mice than in C57BL/6 mice (Fig. 11).
from C57BL/6 mice three days after cisplatin injection
revealed severe RTC injuries, such as proximal tubule
DISCUSSIONbrush border loss, tubule degeneration, tubule necrosis,
and tubule cast formation in the corticomedullary region The present study demonstrates that cisplatin induces
apoptosis of RTCs in association with increased levels(Fig. 7A). Such RTC injury was less severe in kidneys of
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Fig. 7. Histological evaluation of murine kidneys 3 days after cisplatin
injection. Representative kidney sections from C57BL/6 mice (A),
C57BL/6-lpr/lpr mice (B), and TNFR1/ mice (C ). (D) Quantitative
evaluation of morphological tubular damage 3 days after cisplatin injec-
tion is expressed as relative severity on a scale from 0 to 4. Symbols
are: C57BL/6 mice (), C57BL/6-lpr/lpr mice ( ), and TNFR1/ mice
(). Values represent means ( SEM) of kidney sections from at least
five mice. Morphology was scored according to proximal tubule brush
border loss (BB loss), tubule degeneration (Degen.), tubule necrosis
(Necrosis), and cast formation within tubules (Casts). *P  0.05 com-
pared to C57BL/6 mice (magnification, 200).
Fig. 8. Number of apoptotic cells in the murine kidneys 3 days after
cisplatin injection determined by TUNEL assay. Representative kidney
sections are from C57BL/6 mice (A), C57BL/6-lpr/lpr mice (B), and
TNFR1/ mice (C ) (magnification,200). (D) The numbers of TUNEL-
positive cells in the kidney sections at low-power field were counted.
Values represent means ( SEM) of kidney sections from at least five
mice (*P  0.05; **P  0.01 compared to C57BL/6 mice).
Tsuruya et al: Fas and TNFR1 in cisplatin-induced ARF 79
Fig. 9. Cell viability of murine PTCs deter-
mined by WST-1 assay. Symbols are: C57BL/6
mice (), C57BL/6-lpr/lpr mice ( ), and
TNFR1/ mice (). Cell viability was deter-
mined by WST-1 assay as described in the
Methods section. Results are expressed as the
percentage of the value obtained without cis-
platin. The experiments were performed in
triplicate, and the mean values ( SEM) are
plotted. A dose-dependent killing of PTCs by
the 72-hour exposure to cisplatin is shown.
The PTCs of C57BL/6-lpr/lpr mice and
TNFR1/ mice were significantly more resis-
tant to cisplatin stimulation than those of
C57BL/6 mice. **P  0.01 compared to
C57BL/6 mice.
of gene expression of death receptors and ligands, with following reasons: First, in vitro studies have reported
TNF- alone did not induce RTC apoptosis [34, 35]. How-the exception of TNFR1. To our knowledge, this shows
for the first time that ablation of these death receptor ever, it is considered that TNF- is unlikely to act alone
in vivo, but in association with other cytokines such asgenes ameliorates RTC damage and renal dysfunction
induced by cisplatin in vivo and in vitro. interleukin-1 and interferon-	, and with interacting with
many apoptosis regulatory proteins such as c-myc, BaxA previous study by Lieberthal, Triaca and Levine
demonstrated that high concentrations of cisplatin (800 and Bcl2. Therefore, elucidation of the contribution of
TNFR1 requires stimulation of RTCs by such cytokines,mol/L) led to necrotic cell death over a few hours,
whereas much lower concentrations of cisplatin (8 in addition to the stimulation by TNF-. Indeed, they
demonstrated that TNF- promoted marked RTC apo-mol/L) led to apoptosis, which resulted in loss of the
cell monolayer over several days [9]. Our results in mu- ptosis under conditions of serum depletion, with in-
creased Bax expression and reduced Bcl2 expression [35].rine PTCs, demonstrating that annexin V-positive cells
are increased more than PI-positive cells by 72 hours Secondly, unlike Fas, the cytotoxicity mediated by TNFR1
is regulated by two kinds of opposing activities: inductionof incubation with lower concentrations (8 mol/L) of
cisplatin, are in agreement with that study, even taking of apoptosis and activation of the transcriptional factor,
nuclear factor-kappa B (NF-
B). Indeed, a protectiveinto account the different methods of detecting apoptosis
and necrosis (FACS analysis with annexin V and PI effect of TNF- against TNF-mediated apoptosis in the
liver mediated by stimulation of NF-
B has been re-versus DNA gel electrophoresis and morphological anal-
ysis with trypan blue and fluorescent dyes such as ethid- ported [36]. However, in the kidney, many studies have
demonstrated deleterious roles of NF-
B in RTC dam-ium homodimer-1 and H-33342). These findings are in
concordance with recent perspectives on the difference age [37, 38]. Therefore, we believe that it is possible that
the TNF-mediated pathway plays a crucial role in RTCbetween necrosis and apoptosis, that is, that a mild insult
can lead to apoptosis while a severe form of the same death.
Recently, Choi et al reported increased expression ofinsult can induce necrosis [30, 31].
Although there are only a few reports on the involve- Fas, FasL, TNFR1, and signal transduction adaptor mole-
cules such as Fas-associated death domain (FADD),ment of the TNF-mediated pathway in RTC apoptosis [4,
32, 33], those reports have not considered this pathway to TNFR1-associated death domain (TRADD), and cas-
pase-8, in chronic obstructive nephropathy [24]. Ourbe important in the pathogenesis of RTC death for the
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Fig. 10. Percentages of apoptotic cells among
murine PTCs determined by FACS analysis
using annexin V-FITC and PI. Murine PTCs
of C57BL/6 mice (A), C57BL/6-lpr/lpr mice (B),
or TNFR1/ mice (C) were incubated without
cisplatin (Control), or with 8 mol/L cisplatin
for 72 hours and were stained with FITC-con-
jugated annexin V and PI, and analyzed using
a FACSCalibur flow cytometer. Increased ra-
tios of annexin V-positive cells and PI-positive
cells induced by cisplatin stimulation were
seen in PTCs of C57BL/6 mice (A), whereas no
increases were observed in PTCs of C57BL/6-
lpr/lpr mice (B), and TNFR1/ mice (C). The
data represent three independent experiments.
Values on the upper left, upper right, and lower
right indicate the percentages of necrotic, late
apoptotic, and apoptotic cells, respectively.
present study used TNFR1-deficient mice to examine the Tumor necrosis factor- is a pleiotropic, pro-inflam-
matory peptide cytokine that is produced by macro-effect of TNFR1 gene ablation on the susceptibility of
PTCs to cisplatin, and demonstrated that the TNF-medi- phages, T cells, and some non-hematopoietic cells, and
is cytotoxic in picogram quantities. Recent reports haveated apoptotic pathway was involved in cisplatin-induced
RTC death. The roles of TNFR1 and TNFR2 receptors documented the ability of RTCs to express TNF- pro-
tein in response to ischemia, lipopolysaccharide and in-in tubulointerstitial fibrosis of obstructive nephropathy
were reported by Guo et al using the respective knockout terleukin-1, and membrane-associated TNF- is not
limited to hematopoietic cells [39, 40]. Similar to TNF-,mice [22]. However, the relationship between these re-
ceptors and RTC death was not examined, although FasL expression has been demonstrated in RTCs [17, 41].
Our results demonstrated a low level expression of boththese investigators discussed the possible involvement
of TNF-mediated apoptosis in tubular damage. There- TNF- and FasL mRNA in RTCs and their increased ex-
pression in vitro in response to cisplatin, indicating thatfore, to the best of our knowledge, our study is the first
report demonstrating the direct involvement of TNFR1 RTCs may have undergone apoptosis by lymphocyte-
independent activation of the Fas-FasL and TNF-TNFR1in RTC death.
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cell death after exposure to DNA damage or other
stresses [46]. Megyesi et al showed increased levels of
p53 and p21 protein in the kidney during cisplatin-
induced ARF, and demonstrated a renoprotective role
of p21 in this insult using p21 gene knockout mice [1, 27].
We also observed increased levels of p53 and p21 protein
in the nuclei of PTCs in the outer medulla of the rat
kidneys three days after cisplatin injection (unpublished
data). This finding is consistent with a recent study re-
ported by Miyaji et al [47]. However, it is unclear whether
the main role of p53 induction is as an effector of G1 phase
cell cycle arrest or as an effector of apoptosis in cisplatin-
induced RTC death. The physiological significance of
cross talk between Fas and p53 protein in apoptosis is
controversial [48–50]. Studies using p53 knockout mice
are required to elucidate its role in RTC death induced
by cisplatin, and will provide information about mecha-Fig. 11. Effects of ablation of fas and tnfr1 on survival after cisplatin
injection. Cumulative survival rate of C57BL/6 (solid line) vs. C57BL/6- nisms of such insults. In this respect, a study using TNFR
lpr/lpr (dotted line) (P  0.02) and TNFR1/ mice (dashed line) (P  knockout mice and p53 knockout mice, which underwent
0.04), 1 to 5 days after injection with cisplatin is shown as Kaplan-Meier
lung injury by treatment with bleomycin, demonstratedsurvival curve.
that TNFR rather than p53 contributed to apoptosis of
alveolar macrophages and affected the fibroproliferative
response in the lungs of bleomycin-treated mice [51].
systems between adjacent RTCs. This finding is consis- In summary, the present study demonstrates that cis-
tent with previous reports demonstrating that RTCs have platin-induced RTC death is mediated by the Fas-FasL and
antigen-presenting properties reminiscent of those of TNF-TNFR1 pathways. Further studies are necessary to
“professional” antigen-presenting cells such as macro- investigate the role of mitochondrial pathways in RTC
phages [28, 42, 43]. death. Elucidation of such pathways may lead to a better
The association of Fas and TNFR1 on RTCs remains understanding of the mechanisms of RTC atrophy and
unclear. We demonstrated Fas protein expression on tubulointerstitial fibrosis observed in chronic renal failure,
the surface of PTCs of TNFR1-deficient mice at a level in addition to RTC death in ARF, and may provide clues
similar to that in wild-type mice, indicating that Fas ex- for the rational design of novel therapeutic interventions.
pression in RTCs is independent of TNFR1. This finding
suggests that, in the present study, the effect of ablation ACKNOWLEDGMENTS
of each gene on inhibition of RTC damage was indepen- We are grateful to Ms. H. Noguchi for her excellent technical assis-
dent, and that concomitant ablation of both genes could tance and Dr. F. G. Issa for editing of the manuscript. Part of this
study was conducted at the Morphology Core, Graduate School ofbe more effective for inhibition of apoptotic change in
Medical Sciences, Kyushu University.RTCs. However, Zhou et al reported that Fas/TNFR1
double knockout mice exhibited accelerated lympho- Reprint requests to Kazuhiko Tsuruya, M.D., Department of Medi-
cine and Clinical Science, Graduate School of Medical Sciences, Kyushuproliferation and increased rates of autoimmune disease,
University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.associated with high mortality, indicating that the Fas E-mail: tsuruya@intmed2.med.kyushu-u.ac.jp
and TNFR1 signaling and apoptosis pathways may com-
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